DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
CHS-828 is an investigational drug.
There have been 14 clinical trials for CHS-828. The most recent clinical trial was a Phase 3 trial, which was initiated on May 21st 2017.
The most common disease conditions in clinical trials are Psoriasis, Arthritis, Rheumatoid, and Marijuana Abuse. The leading clinical trial sponsors are Coherus Biosciences, Inc., Baxalta US Inc., and Daiichi Sankyo Co., Ltd.
There are seventeen US patents protecting this investigational drug and two hundred and forty-nine international patents.
Recent Clinical Trials for CHS-828
|Improving Pain Control in Paraesophageal Hernia Repair: Intravenous Lidocaine Versus Placebo||Atrium Health||Phase 4|
|Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC)||Queen's University||Phase 4|
|Study to Assess the Pharmacokinetic and Pharmacodynamic Bioequivalence of CHS-1701 With Neulasta||Coherus Biosciences, Inc.||Phase 1|
Top disease conditions for CHS-828
Top clinical trial sponsors for CHS-828
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|CHS-828||See Pricing||Compounds and compositions for the inhibition of NAMPT||Forma TM, LLC (Watertown, MA) Genentech, Inc. (South San Francisco, CA)||See Pricing|
|CHS-828||See Pricing||Compounds and compositions for the inhibition of NAMPT||FORMA TM, LLC (Watertown, MA) Genentech, Inc. (South San Francisco, CA)||See Pricing|
|CHS-828||See Pricing||N-cyano-N'-pyridylguanidines as serotonin antagonists||Leo Pharmaceutical Products Ltd. (Ballerup, DK)||See Pricing|
|CHS-828||See Pricing||Cyanoguanidine prodrugs||Leo Pharmaceutical Products Ltd. A/S (Ballerup, DK)||See Pricing|
|CHS-828||See Pricing||Cyanoguanidine prodrugs||LEO Pharma A/S (Ballerup, DK)||See Pricing|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|